Genius Group appoints Inspiral Architects to lead the Iconic Design of Genius City

Genius Group appoints Inspiral Architects to lead the Iconic Design of Genius City GlobeNewswire November 12, 2025 SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) — Genius Group Limited (NYSE American: GNS) (“Genius Group” or the “Company”), a leading AI-powered, Bitcoin-first education group, today announced the appointment of Inspiral Architects for the iconic design of Genius City […]

NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules

NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules GlobeNewswire November 12, 2025 BELTSVILLE, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to developing novel therapies to treat cancer, today announced that it has entered into definitive agreements with the

Strategy A Crust (SAC) Unveils Decentralized AI Network, Pioneering the Future of Trustworthy Artificial Intelligence

Strategy A Crust (SAC) Unveils Decentralized AI Network, Pioneering the Future of Trustworthy Artificial Intelligence GlobeNewswire November 12, 2025 Grand Cayman, Cayman Islands, Nov. 12, 2025 (GLOBE NEWSWIRE) — As artificial intelligence becomes central to global technological infrastructure, Strategy A Crust (SAC) has emerged with a bold vision: to decentralize AI and redefine how trust

Aeries Technology Announces Completion of Q2 FY2026 Earnings Call

Aeries Technology Announces Completion of Q2 FY2026 Earnings Call Leadership Highlights Disciplined Growth Momentum Following Two Consecutive Profitable Quarters. GlobeNewswire November 12, 2025 NEW YORK, Nov. 12, 2025 (GLOBE NEWSWIRE) — Aeries Technology, Inc. (NASDAQ: AERT) (“Aeries” or the “Company”), a global leader in AI-powered business transformation and Global Capability Center (GCC) services, today announced

Rezolve Ai’s Acceleration Toward $500 Million ARR Exit Rate for 2026 Attracts Industry Titans from Apple, Google, Microsoft, SAP and Tata Digital

Rezolve Ai's Acceleration Toward $500 Million ARR Exit Rate for 2026 Attracts Industry Titans from Apple, Google, Microsoft, SAP and Tata Digital Top global executives are joining Rezolve Ai to lead the trillion-dollar Agentic Commerce transformation GlobeNewswire November 12, 2025 NEW YORK , Nov. 12, 2025 (GLOBE NEWSWIRE) — Rezolve Ai (NASDAQ: RZLV), the AI-commerce

Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results

Annovis Provides Corporate Updates and Reports Third Quarter 2025 Financial Results GlobeNewswire November 12, 2025 MALVERN, Pa., Nov. 12, 2025 (GLOBE NEWSWIRE) — Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), today provided

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization

BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization GlobeNewswire November 12, 2025 KUALA LUMPUR, Malaysia and SINGAPORE, Nov. 12, 2025 (GLOBE NEWSWIRE) — BioNexus Gene Lab Corp. (“BGLC,” Nasdaq: BGLC) today announced it has entered into definitive agreements with Fidelion Diagnostics Pte. Ltd. (“Fidelion”) and Tongshu

BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025

BullFrog AI to Present bfPREP at the AI Drug Discovery & Development Summit 2025 Technical insights session to highlight human-in-the-loop AI agent workflows in drug development GlobeNewswire November 12, 2025 GAITHERSBURG, Md., Nov. 12, 2025 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), a technology-enabled drug development company

Scroll to Top